$Astellas Pharma (4503.JP)$ Astellas has been approved in th...
Astellas has been approved in the United States as a treatment for age-related macular degeneration, which causes poor eyesight.
As a result, the stock price went up a lot 😊
When it comes to age-related macula, it damages the retina and leads to poor eyesight.
What suppresses that damage is this medicine, and it's a very new drug 😊
Astellas had ophthalmology-related research and acquisitions of related companies for a long time, so I was really looking forward to it 😊
Moreover, eye diseases are in demand by many people, and I think they will be closely related to everyday life in the future, like lifestyle diseases 😊
So, it's strong to be able to monopolize this field for a while with this new drug 😊
Since stable profits can also be made, I think shareholder returns will also be actively promoted 😊
![$Astellas Pharma (4503.JP)$ Astellas has been approved in the United States as a treatment for age-related macular degeneration, which causes poor eyesight. As ...](https://sgsnsimg.moomoo.com/feed_image/181460965/d1ab1a6d3a803826982a8c0d9f5407e1.jpg/bigmoo)
I really want companies that develop drugs for such intractable diseases to do their best, and I want to support them 👍
I want to keep getting really excited 😊
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment